Claritev Corporation reports developments for a healthcare technology, data and insights company serving the U.S. healthcare system. The company provides technology-enabled solutions built on claims expertise, advanced analytics and AI to support affordability, price transparency, payment integrity, network optimization and benefits design for payers, employers, patients, providers and third parties.
Recurring news includes quarterly results, guidance, investor-day strategy, conference participation, AI-focused leadership and workflow updates, product-roadmap themes and Claritev Cares community initiatives. Company updates often connect its analytics platform with healthcare cost management, revenue integrity and vertical-market expansion.
Claritev (CTEV) has been selected by General Dynamics Information Technology (GDIT) to support the CDC’s World Trade Center (WTC) Health Program by administering its Nationwide Provider Network (NPN).
Claritev will use its existing provider network to connect 9/11 responders and survivors who live outside the New York metropolitan area with healthcare providers experienced in conditions related to 9/11 exposures. The company’s responsibilities include network development, credentialing, and maintaining provider access nationwide for members receiving care for certified WTC-related health conditions. Claritev currently serves more than 750 healthcare payers, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers.
Claritev (CTEV) released its 2025 Corporate Responsibility Report, outlining progress in responsible AI, employee engagement, community impact, and sustainable operations across its healthcare technology business.
Key 2025 actions include formalizing a dedicated Responsible AI function, appointing the company’s first Head of Responsible AI, and joining the Coalition for Health AI. Claritev also launched the Workforward program and an enterprise-wide engagement strategy focused on Career, Cause, and Community, and created the Claritev Cares Foundation, a 501(c)(3) focused on improving healthcare access and equity.
The company reports continued workplace recognition and states that the full report is available on its website.
Claritev (CTEV) appointed AI expert Ben Letham to its Board of Directors, effective 14 September 2026, filling an existing Board vacancy.
Letham is a research scientist at Meta (META) and co-creator of Prophet, an open-source forecasting tool aimed at enabling non-experts to derive insights from data. His background spans large-scale digital experimentation, applied data analysis, and interpretable models for decision-making, including early work at Massachusetts General Hospital and a Ph.D. in Operations Research from MIT. Claritev said his appointment is intended to support its tech-driven, AI-focused growth strategy and the development of AI-led products and enterprise AI transformation in healthcare.
Claritev (CTEV) announced its 2026 Claritev Cares Rural Health Grants for Fairfield Memorial Hospital in Illinois and Kodiak Community Health Center in Alaska.
Fairfield Memorial will use the funding to complete purchase of a portable point-of-care ultrasound system that clinicians can bring directly to patients across the hospital, closing a local fundraising gap. Kodiak Community Health Center will apply its grant to continue the MAVEN Project for another year, enabling local clinicians to consult volunteer specialists while patients remain on Kodiak Island. In the first eight months, 42 consultations were initiated and 82% avoided formal referrals. Claritev Cares selects recipients based on local need, expected impact, and ability to quickly translate funds into patient care, extending a rural grantmaking effort that began in 1995.
Claritev (NYSE: CTEV)/b) announced that its management team will meet investors at several healthcare conferences in September 2026. These include the Wells Fargo 21st Annual Healthcare Conference on September 9 in Boston, the J.P. Morgan 4th Annual Healthcare Credit Conference on September 10 in Nashville, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15 in New York, featuring a 9:15 a.m. ET presentation and one-on-one meetings, with a webcast available via the company’s investor website.
Claritev (NYSE: CTEV) announced that Marpai (OTCQX: MRAI) has expanded its relationship with Claritev beyond use of the PHCS Network for out-of-network access to include comprehensive pre- and post-payment integrity solutions across the claims lifecycle.
Marpai will adopt additional Claritev services such as Advanced Code Editing, Itemized Bill Review, DRG Validation, Data Mining, Coordination of Benefits, and Specialty Claim Reviews. According to Claritev, these capabilities are expected to help identify millions of dollars in potential savings opportunities for Marpai’s self-funded employer clients and improve claim payment accuracy. The expanded services are expected to be implemented within the next 90 days.
Claritev (NYSE: CTEV) reported Q2 2026 revenues of $257.5 million, up 6.6% from $241.6 million in Q2 2025. Net loss was $59.2 million, versus $62.6 million a year ago. Adjusted EBITDA rose 1.1% to $155.8 million, with a margin of 60.5% compared to 63.8%.
Net cash provided by operating activities increased to $92.7 million from $61.2 million, and Free Cash Flow improved to $54.6 million from $36.6 million. Claritev reported more than $70 million in bookings in the first half of 2026 toward a full‑year target of $100 million. The company raised 2026 guidance to $1.0–$1.02 billion in revenue, Adjusted EBITDA of $610–$620 million, and Free Cash Flow of $5–$15 million.
At June 30, 2026, total assets were $4.76 billion, long‑term debt was $4.59 billion plus $70 million drawn on the 2025 Revolving Credit Facility, and total shareholders’ deficit was $287.8 million.
Claritev Corporation (NYSE: CTEV) announced that its management team will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston. The appearance includes a fireside chat on Tuesday, August 11, 2026, at 10:00 a.m. ET, with a live webcast and audio archive available via Claritev’s investor relations website.
Claritev (NYSE: CTEV) reported that newly released 2025 data from the Centers for Medicare & Medicaid Services show it handled more federal Independent Dispute Resolution (IDR) claims than any other non-payer, making it the leading independent IDR administrator by volume.
According to Claritev, clients’ offers were selected in 20% of applicable 2025 determinations versus 12% industrywide, rising to 24% vs. 15% in Q4. The company priced more than 1 million claims using qualifying payment amount methodology, negotiated about 400,000 post-payment disputes, and managed roughly 270,000 federal IDR arbitrations, demonstrating national scale.
CMS data cited by Claritev show federal IDR filings reached 2.5 million disputes in 2025 versus 1.5 million in 2024, with total awards exceeding $15 billion, over triple 2024 levels. Claritev said it is investing in AI-native data, analytics, and workflow tools to help clients manage rising No Surprises Act dispute volumes and eligibility issues.
Claritev (NYSE: CTEV) and SAVVI Financial have launched Claritev Benefit Decision Support, a white-labeled solution that combines Claritev’s healthcare claims intelligence with SAVVI’s AI-powered financial Decision Intelligence platform. The tool aims to help employers offer personalized benefits guidance and enable employees to choose healthcare coverage and financial options aligned with their historical utilization and financial situation.
The solution integrates with leading HRIS, HCM, and benefits administration platforms, uses claims-informed, survey-less recommendations, and supports health-and-wealth optimization and claims-triggered notifications to improve engagement with medical and voluntary benefits, according to the companies.